Technical Analysis for GOVX - GeoVax Labs, Inc.

Grade Last Price % Change Price Change
F 0.40 2.54% 0.01
GOVX closed up 2.54 percent on Wednesday, December 6, 2023, on 1.54 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.54%
NR7 Range Contraction 2.54%
Lower Bollinger Band Walk Weakness 2.54%
Inside Day Range Contraction 2.54%
Wide Bands Range Expansion 2.54%
Down 3 Days in a Row Weakness 2.54%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 19 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
2x Volume Pace about 19 hours ago
1.5x Volume Pace about 19 hours ago
Down 5% about 19 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GeoVax Labs, Inc. Description

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Clinical Medicine Infectious Diseases Immunotherapies Vaccines Hepatitis B Allergy Department Of Defense Viruses HIV Immunodeficiency Virus Malaria U.S. Department Of Defense Virology Fever Ebola Zika Chronic Hepatitis Scripps Vaccinia

Is GOVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.39
52 Week Low 0.36
Average Volume 220,837
200-Day Moving Average 0.59
50-Day Moving Average 0.51
20-Day Moving Average 0.49
10-Day Moving Average 0.44
Average True Range 0.04
RSI (14) 28.06
ADX 30.53
+DI 6.89
-DI 32.57
Chandelier Exit (Long, 3 ATRs) 0.46
Chandelier Exit (Short, 3 ATRs) 0.47
Upper Bollinger Bands 0.60
Lower Bollinger Band 0.37
Percent B (%b) 0.13
BandWidth 47.95
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.0118
Fundamentals Value
Market Cap 5.53 Million
Num Shares 13.8 Million
EPS -5.62
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 4.33
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.47
Resistance 3 (R3) 0.47 0.44 0.46
Resistance 2 (R2) 0.44 0.42 0.44 0.46
Resistance 1 (R1) 0.42 0.41 0.43 0.42 0.45
Pivot Point 0.39 0.39 0.39 0.39 0.39
Support 1 (S1) 0.37 0.37 0.38 0.38 0.35
Support 2 (S2) 0.34 0.36 0.34 0.34
Support 3 (S3) 0.32 0.34 0.34
Support 4 (S4) 0.33